Radicle Science
The next generation of clinical trials
Los Angeles, United States · Founded 2020 · $16.0M raised
- Headquarters
- Los Angeles, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- radiclescience.com
- Total Funding
- $16.0M
- Last Round
- $10.0M Growth EquityMar 2026
- Rounds
- 2
About
Radicle Science validates natural product efficacy through large-scale, diverse clinical trials at unprecedented speed and affordability. The Proof-as-a-Service model combines rigorous clinical research (RCTs, adaptive trials), AI analysis, and real-world evidence to generate clinically-proven health insights. Platform features 100+ validated biomarkers, 500-1000s of participants per trial, and results in 180 days. Co-founded by Pelin Thorogood and Dr. Jeff Chen.
Summary
Radicle Science is a Healthcare company based in Los Angeles, United States, founded in 2020. It has raised $16.0M in total across 2 rounds, most recently a $10.0M Growth Equity round in Mar 2026. Investors include Resilience Reserve, Plug and Play and Untapped Capital.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company